Short Description

Detection of Minimal Residual Disease (MRD) in Acute lymphoblastic leukemia predicts outcome. This assay can identify patients at higher/lower risk of relapse. Detection of MRD is important for risk assessment and stratification of therapy.

PreTest Information

It is mandatory to provide Date & Time of sampling, Previous immunophenotype report & Clinical history.

Detail Description

Understanding Minimal Residual Disease (MRD) Analysis for B-ALL: Symptoms, Diagnosis, and Test Cost in India

Minimal residual disease (MRD) analysis is a diagnostic test that is used to determine the presence of cancer cells in the body after treatment. This test is commonly used for patients with B-cell acute lymphoblastic leukemia (B-ALL), which is a type of blood cancer that affects white blood cells.

In India, the cost of MRD analysis for B-ALL is around INR 14,000. This cost may vary depending on the location and the laboratory that performs the test. However, it is important to note that MRD analysis is an essential test for patients with B-ALL, as it helps to monitor their response to treatment and detect any potential relapse.

Symptoms of B-ALL

B-ALL is a type of blood cancer that affects the bone marrow, which is responsible for producing blood cells. The symptoms of B-ALL may vary depending on the stage of the disease, but some common symptoms include:

• Fatigue
• Weakness
• Fever
• Night sweats
• Easy bruising or bleeding
• Swollen lymph nodes
• Pain in the bones or joints
• Loss of appetite or weight loss

If you experience any of these symptoms, it is important to consult a healthcare professional for further evaluation and diagnosis.

Diagnosis of B-ALL

The diagnosis of B-ALL typically involves a combination of tests, including:

• Physical examination
• Blood tests
• Bone marrow biopsy
• Imaging tests, such as X-rays or CT scans

If B-ALL is diagnosed, treatment may involve chemotherapy, radiation therapy, and/or stem cell transplantation.

MRD Analysis for B-ALL

MRD analysis is a sensitive test that is used to detect the presence of cancer cells in the body after treatment. This test is particularly useful for patients with B-ALL, as it helps to monitor their response to treatment and detect any potential relapse.

MRD analysis involves the use of specialized techniques to detect and quantify cancer cells in the blood or bone marrow. This test is typically performed at regular intervals during and after treatment to monitor the patient's response to therapy.

Conclusion

B-ALL is a type of blood cancer that requires prompt diagnosis and treatment. MRD analysis is an essential test for patients with B-ALL, as it helps to monitor their response to treatment and detect any potential relapse. In India, the cost of MRD analysis for B-ALL is around INR 14,000. If you experience any symptoms of B-ALL, it is important to consult a healthcare professional for further evaluation and diagnosis.

At DNA Labs India, we offer MRD analysis for B-ALL and other types of cancer. Our state-of-the-art laboratory is equipped with the latest technology and staffed by experienced professionals. Contact us today to learn more about our testing services.

Detection of Minimal Residual Disease (MRD) in Acute lymphoblastic leukemia predicts outcome. This assay can identify patients at higher/lower risk of relapse. Detection of MRD is important for risk assessment and stratification of therapy.